echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Lancet: Update on the world's largest real-life prospective study!

    The Lancet: Update on the world's largest real-life prospective study!

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Lung cancer (LC) is the leading cause of cancer death worldwide


    Nonetheless, geographic differences in incidence differed between women and men, which were attributed to historical gender differences in smoking


    To capture the consequences of this changing social and health environment, two previous epidemiological studies, KBP-2000 and KBP-2010, conducted every ten years in France, were able to characterize lung cancer and its changes: more more women, more never-smokers and more adenocarcinomas


    In 2020, 82 centers included 8999 patients diagnosed with LC


    The proportion of non-smokers in 2020 (12.


    In 2020, at diagnosis, 57.


    The KBP-CPHG-2020 study confirmed a 20-year trend that had been observed previously, showing a higher proportion of women with LC and never-smokers compared to the previous cohort


    Original source:

    Didier Debieuvre, et al.


     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.